Activating <i>KRAS</i> mutations frequently occur in pancreatic, colorectal, and lung adenocarcinomas. While many attempts have been made to target oncogenic KRAS, no clinically useful therapies currently exist. Most efforts to target KRAS have focused on inhibiting the mutant protein; a less explored approach involves targeting KRAS at the transcriptional level. The promoter element of the <i>KRAS</i> gene contains a GC-rich nuclease hypersensitive site with three potential DNA secondary structure-forming regions. These are referred to as the Near-, Mid-, and Far-regions, on the basis of their proximity to the transcription start site. As a result of transcription-induced negative superhelicity, these regions can open up to form unique DNA...
The human KRAS transcript contains a G-rich 5\ue2\u80\ub2-UTR sequence (77% GC) harboring several G4...
MYC is overexpressed in most types of tumors, but a means to selectively decrease its expression is ...
It is well known that B-form DNA is not the only structure formed in the genome. In addition to the ...
The oncogene KRAS is involved in the pathogenesis of many tumors such as pancreatic, lung and colore...
Non-canonical base pairing within guanine-rich DNA and RNA sequences can produce G-quartets, whose s...
KRAS is a GTPase involved in the proliferation signaling of several growth factors. The KRAS gene is...
The role of G-quadruplexes (G4) which can coexist with canonical duplex DNA in the human genome is s...
The human KRAS proto-oncogene contains a critical nuclease hypersensitive element (NHE) upstream of ...
KRAS is a well-validated anti-cancer therapeutic target, whose transcriptional downregulation has be...
L'oncogène KRAS code pour une protéine GTPasique hautement mutée qui agit comme un « interrupteur » ...
KRAS is one of the most mutated genes in human cancer. Its crucial role in the tumourigenesis of pan...
The ras genes are promising therapeutic targets in anticancer strategies. Somatic mutations on the g...
Suppression of oncogenes transcription represents an ideal tool to integrate the currently available...
L'oncogène KRAS code pour une protéine GTPasique hautement mutée qui agit comme un « interrupteur » ...
DNA G-quadruplexes (G4s) form in relevant genomic regions and intervene in several biological proces...
The human KRAS transcript contains a G-rich 5\ue2\u80\ub2-UTR sequence (77% GC) harboring several G4...
MYC is overexpressed in most types of tumors, but a means to selectively decrease its expression is ...
It is well known that B-form DNA is not the only structure formed in the genome. In addition to the ...
The oncogene KRAS is involved in the pathogenesis of many tumors such as pancreatic, lung and colore...
Non-canonical base pairing within guanine-rich DNA and RNA sequences can produce G-quartets, whose s...
KRAS is a GTPase involved in the proliferation signaling of several growth factors. The KRAS gene is...
The role of G-quadruplexes (G4) which can coexist with canonical duplex DNA in the human genome is s...
The human KRAS proto-oncogene contains a critical nuclease hypersensitive element (NHE) upstream of ...
KRAS is a well-validated anti-cancer therapeutic target, whose transcriptional downregulation has be...
L'oncogène KRAS code pour une protéine GTPasique hautement mutée qui agit comme un « interrupteur » ...
KRAS is one of the most mutated genes in human cancer. Its crucial role in the tumourigenesis of pan...
The ras genes are promising therapeutic targets in anticancer strategies. Somatic mutations on the g...
Suppression of oncogenes transcription represents an ideal tool to integrate the currently available...
L'oncogène KRAS code pour une protéine GTPasique hautement mutée qui agit comme un « interrupteur » ...
DNA G-quadruplexes (G4s) form in relevant genomic regions and intervene in several biological proces...
The human KRAS transcript contains a G-rich 5\ue2\u80\ub2-UTR sequence (77% GC) harboring several G4...
MYC is overexpressed in most types of tumors, but a means to selectively decrease its expression is ...
It is well known that B-form DNA is not the only structure formed in the genome. In addition to the ...